Study on the mechanism by which Xuanfu Hua Tang increases sensitivity of hepatocellular carcinoma cells to sorafenib by antagonizing the Notch1 pathway through HIF-2α

BackgroundIt is crucial to explore ways to increase the sensitivity of hepatocellular carcinoma cells to sorafenib.MethodsThe HepG2 and Huh7 cell lines with overexpressed HIF-2α were constructed. The cells were treated with Xuanfu Hua Tang (Xuanfu HT) containing serum and sorafenib separately and by...

詳細記述

書誌詳細
出版年:Frontiers in Oncology
主要な著者: Wenzhao Luo, Xian Li, Yiwan Shang, Zhen Chen, Yinglin Cui
フォーマット: 論文
言語:英語
出版事項: Frontiers Media S.A. 2025-05-01
主題:
オンライン・アクセス:https://www.frontiersin.org/articles/10.3389/fonc.2025.1552480/full